Davion Healthcare Acquires Intellectual Property Relating To Two Medical Technologies, WoundSkan And Spektra Lateral Flow Test, For Total Consideration Of $25M
Davion Healthcare Plc (NASDAQ:DAVI) ("Davion" or the "Company"), a next-generation digital healthcare company developing proprietary health monitoring technologies, today announces that it has completed
Davion bought two medical technology inventions for $25 million. When companies buy new technology, watch if it helps them make money or solve real problems.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.